In one paragraphArticle in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Nahomi MiyamotoResearch Institute of Health Innovation, Hirosaki University, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.ORCID 0009-0007-7924-4735 Tohru YamaguchiResearch Center for Health-Medical Data Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.ORCID 0000-0002-5946-1042 Yoshinori TamadaResearch Center for Health-Medical Data Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.ORCID 0000-0003-3483-9712 Seiya YamayoshiDivision of Virology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-0071, Japan.ORCID 0000-0001-7768-5157 Koichi MurashitaResearch Institute of Health Innovation, Hirosaki University, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.
Ken ItohDepartment of Stress Response Science, Biomedical Research Center, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.ORCID 0000-0002-5518-0729 Seiya ImotoDivision of Health-Medical Intelligence, Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-0071, Japan.ORCID 0000-0002-2989-308X Norihiro SaitoDepartment of Clinical Laboratory Medicine, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.ORCID 0000-0003-2239-6846 Tatsuya MikamiDepartment of Preemptive Medicine, Innovation Center for Health Promotion, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.ORCID 0000-0002-6657-6446 Shigeyuki NakajiDepartment of Preemptive Medicine, Innovation Center for Health Promotion, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki-shi 036-8562, Aomori, Japan.ORCID 0000-0002-4190-5151 Funding
the Japan Science and Technology Agency JPMJCE1302, JPMJCA2201, and JPMJPF2210
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Bayesian networkcarrier moleculesCOVID-19 vaccineIwaki Health Promotion Projectmachine learningSARS-CoV-2 virus
Identifiers
PMID41746038
PMCPMC12945091
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390